סינרייז

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

C - 1 ESTERASE INHIBITOR HUMAN 500 UNITS

Disponible desde:

NEOPHARM CURE (2005) LTD

Código ATC:

B02AB03

formulario farmacéutico:

LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION

Vía de administración:

I.V

Fabricado por:

SANQUIN BLOOD SUPPLY FOUNDATION, THE NETHERLANDS

Grupo terapéutico:

C1-INHIBITOR

indicaciones terapéuticas:

Treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.

Fecha de autorización:

2013-08-01